343 related articles for article (PubMed ID: 24378862)
21. [Recreational drugs: the complication's pleasure?].
Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review.
Alvarez JC; Fabresse N; Larabi IA
Curr Pharm Des; 2017 Jan; 23(36):5487-5495. PubMed ID: 28677501
[TBL] [Abstract][Full Text] [Related]
23. Chemistry, pharmacology, and metabolism of emerging drugs of abuse.
Maurer HH
Ther Drug Monit; 2010 Oct; 32(5):544-9. PubMed ID: 20683389
[TBL] [Abstract][Full Text] [Related]
24. Baths salts, spice, and related designer drugs: the science behind the headlines.
Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
[TBL] [Abstract][Full Text] [Related]
25. "Not for human consumption": a review of emerging designer drugs.
Musselman ME; Hampton JP
Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
[TBL] [Abstract][Full Text] [Related]
26. [Synthetic drugs: the new low-cost landscape of drugs].
Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
[TBL] [Abstract][Full Text] [Related]
27. New drugs of abuse.
Rech MA; Donahey E; Cappiello Dziedzic JM; Oh L; Greenhalgh E
Pharmacotherapy; 2015 Feb; 35(2):189-97. PubMed ID: 25471045
[TBL] [Abstract][Full Text] [Related]
28. Analysis of a new drug of abuse: cathinone derivative 1-(3,4-dimethoxyphenyl)-2-(ethylamino)pentan-1-one.
Weiß JA; Taschwer M; Kunert O; Schmid MG
J Sep Sci; 2015 Mar; 38(5):825-8. PubMed ID: 25545103
[TBL] [Abstract][Full Text] [Related]
29. Analytical toxicology of emerging drugs of abuse--an update.
Meyer MR; Peters FT
Ther Drug Monit; 2012 Dec; 34(6):615-21. PubMed ID: 23131695
[TBL] [Abstract][Full Text] [Related]
30. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
[TBL] [Abstract][Full Text] [Related]
31. "Bath salts" and "plant food" products: the experience of one regional US poison center.
Murphy CM; Dulaney AR; Beuhler MC; Kacinko S
J Med Toxicol; 2013 Mar; 9(1):42-8. PubMed ID: 22733603
[TBL] [Abstract][Full Text] [Related]
32. Bath Salts Abuse Leading to New-Onset Psychosis and Potential for Violence.
John ME; Thomas-Rozea C; Hahn D
Clin Schizophr Relat Psychoses; 2017; 11(2):120-124. PubMed ID: 24951715
[TBL] [Abstract][Full Text] [Related]
33. [New psychoactive substances and their prevalence in the Czech Republic].
Mravčík V; Běláčková V; Grohmannová K; Zábranský T
Cas Lek Cesk; 2015; 154(5):216-21. PubMed ID: 26612328
[TBL] [Abstract][Full Text] [Related]
34. Designer drugs 2015: assessment and management.
Weaver MF; Hopper JA; Gunderson EW
Addict Sci Clin Pract; 2015 Mar; 10(1):8. PubMed ID: 25928069
[TBL] [Abstract][Full Text] [Related]
35. Synthetic cathinones: "a khat and mouse game".
Katz DP; Bhattacharya D; Bhattacharya S; Deruiter J; Clark CR; Suppiramaniam V; Dhanasekaran M
Toxicol Lett; 2014 Sep; 229(2):349-56. PubMed ID: 24973490
[TBL] [Abstract][Full Text] [Related]
36. Designer drugs: a medicinal chemistry perspective.
Carroll FI; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA
Ann N Y Acad Sci; 2012 Feb; 1248():18-38. PubMed ID: 22092008
[TBL] [Abstract][Full Text] [Related]
37. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
Shanks KG; Dahn T; Behonick G; Terrell A
J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
[TBL] [Abstract][Full Text] [Related]
38. Novel Drugs of Abuse.
Wang GS; Hoyte C
Pediatr Rev; 2019 Feb; 40(2):71-78. PubMed ID: 30709973
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of new designer drugs and their legal status in Japan].
Kikura-Hanajiri R; Uchiyama N; Kawamura M; Ogata J; Goda Y
Yakugaku Zasshi; 2013; 133(1):31-40. PubMed ID: 23292017
[TBL] [Abstract][Full Text] [Related]
40. Substituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use.
Gunderson EW; Kirkpatrick MG; Willing LM; Holstege CP
J Addict Med; 2013; 7(3):153-62. PubMed ID: 23732954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
